InsidersTradesSigma
에임드바이오: management transactions · South Korea · DART (FSS)
DART:company-205386KR·DART (FSS)Mcap 2136.4Bn€Healthcare
Browse the full insider trade history of 에임드바이오, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, 에임드바이오 has logged 3 reports. Market capitalisation: €2,136.4bn. The latest transaction was filed on 17 March 2026 — Sale. Among the most active insiders: 인터베스트. The full history is accessible without an account.
3
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€69m
2 ops.
Sell Volume
Financial data
33300.00 €
Analyst consensus
Balance sheet & cash
Market cap2136.40 Bn€
Debt / Equity1%
Profitability & ownership
ROE4.2%
ROA10.5%
% insiders40.5%
% institutions16.9%
Last declaration on 17 March 2026